Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2026-01-03 @ 4:50 PM
Study NCT ID:
NCT02942758
Status:
TERMINATED
Last Update Posted:
2024-05-08
First Post:
2016-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML
Sponsor:
University Hospital Regensburg
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-25
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-18
First Submit QC Date:
None
Study First Post Date:
2016-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-07
Last Update Post Date:
2024-05-08
Last Update Post Date Type:
ACTUAL